BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10026280)

  • 1. Probing the binding of coumarins and cyclothialidines to DNA gyrase.
    Kampranis SC; Gormley NA; Tranter R; Orphanides G; Maxwell A
    Biochemistry; 1999 Feb; 38(7):1967-76. PubMed ID: 10026280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the binding of the coumarin drugs using peptide fragments of DNA gyrase B protein.
    Garrido SS; Scatigno AC; Trovatti E; Carvalho DC; Marchetto R
    J Pept Res; 2005 May; 65(5):502-11. PubMed ID: 15853944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of DNA gyrase with the bacterial toxin CcdB: evidence for the existence of two gyrase-CcdB complexes.
    Kampranis SC; Howells AJ; Maxwell A
    J Mol Biol; 1999 Oct; 293(3):733-44. PubMed ID: 10543963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 4.2 kDa synthetic peptide as a potential probe to evaluate the antibacterial activity of coumarin drugs.
    Scatigno AC; Garrido SS; Marchetto R
    J Pept Sci; 2004 Sep; 10(9):566-77. PubMed ID: 15473264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. coli complexed with one of the most potent coumarin inhibitors, clorobiocin.
    Tsai FT; Singh OM; Skarzynski T; Wonacott AJ; Weston S; Tucker A; Pauptit RA; Breeze AL; Poyser JP; O'Brien R; Ladbury JE; Wigley DB
    Proteins; 1997 May; 28(1):41-52. PubMed ID: 9144789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a residue involved in transition-state stabilization in the ATPase reaction of DNA gyrase.
    Smith CV; Maxwell A
    Biochemistry; 1998 Jul; 37(27):9658-67. PubMed ID: 9657678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of coumarin antibiotics with fragments of DNA gyrase B protein.
    Gormley NA; Orphanides G; Meyer A; Cullis PM; Maxwell A
    Biochemistry; 1996 Apr; 35(15):5083-92. PubMed ID: 8664301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography.
    Lewis RJ; Singh OM; Smith CV; Skarzynski T; Maxwell A; Wonacott AJ; Wigley DB
    EMBO J; 1996 Mar; 15(6):1412-20. PubMed ID: 8635474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
    Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
    J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the binding site for cyclothialidine on the B subunit of DNA gyrase.
    Nakada N; Gmünder H; Hirata T; Arisawa M
    J Biol Chem; 1995 Jun; 270(24):14286-91. PubMed ID: 7782285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature-sensitive suppressor mutations of the Escherichia coli DNA gyrase B protein.
    Blance SJ; Williams NL; Preston ZA; Bishara J; Smyth MS; Maxwell A
    Protein Sci; 2000 May; 9(5):1035-7. PubMed ID: 10850814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The entropic penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: a thermodynamic and crystallographic study.
    Holdgate GA; Tunnicliffe A; Ward WH; Weston SA; Rosenbrock G; Barth PT; Taylor IW; Pauptit RA; Timms D
    Biochemistry; 1997 Aug; 36(32):9663-73. PubMed ID: 9245398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization of inhibitor complexes of an N-terminal 24 kDa fragment of the DNA gyrase B protein.
    Lewis RJ; Singh OM; Smith CV; Maxwell A; Skarzynski T; Wonacott AJ; Wigley DB
    J Mol Biol; 1994 Aug; 241(1):128-30. PubMed ID: 8051702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA cleavage is not required for the binding of quinolone drugs to the DNA gyrase-DNA complex.
    Critchlow SE; Maxwell A
    Biochemistry; 1996 Jun; 35(23):7387-93. PubMed ID: 8652515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition.
    Heddle JG; Blance SJ; Zamble DB; Hollfelder F; Miller DA; Wentzell LM; Walsh CT; Maxwell A
    J Mol Biol; 2001 Apr; 307(5):1223-34. PubMed ID: 11292337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization.
    Miller JR; Herberg JT; Tomilo M; McCroskey MC; Feilmeier BJ
    Anal Biochem; 2007 Jun; 365(1):132-43. PubMed ID: 17395144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacterial type II topoisomerases as targets for antibacterial drugs].
    Pietrusiński M; Staczek P
    Postepy Biochem; 2006; 52(3):271-82. PubMed ID: 17201062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5'-methyl group of the noviose.
    Lafitte D; Lamour V; Tsvetkov PO; Makarov AA; Klich M; Deprez P; Moras D; Briand C; Gilli R
    Biochemistry; 2002 Jun; 41(23):7217-23. PubMed ID: 12044152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor.
    Nakada N; Gmünder H; Hirata T; Arisawa M
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1966-73. PubMed ID: 7811004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of DNA gyrase-mediated illegitimate recombination: characterization of Escherichia coli gyrA mutations that confer hyper-recombination phenotype.
    Ashizawa Y; Yokochi T; Ogata Y; Shobuike Y; Kato J; Ikeda H
    J Mol Biol; 1999 Jun; 289(3):447-58. PubMed ID: 10356321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.